iMeds.se

Urozosin

Information för alternativet: Urozosin 5 Mg Depottablett, visa andra alternativ

PACKAGE LEAFLET: INFORMATION FOR THE USER

Urozosin5 mg,prolonged-release tablets


Alfuzosin hydrochloride


Read all of this leaflet carefully before you start taking this medicinebecause it contains important information for you.


What is in this leaflet:


What Urozosin is and what it is used for

What you need to know before you take Urozosin

How to take Urozosin

Possible side effects

How to store Urozosin

Contents of the pack and other information


1. What Urozosinis and what it is used for


Urozosinbelongs to a group of medicines called alpha-adrenoreceptor antagonists or alpha-blockers.


It is used to treat moderate to severe symptoms caused by an enlarged prostate gland, a condition that is also called benign prostatic hyperplasia. Enlarged prostate glands can cause urinary problems such as frequent and difficult urination, especially at night. Alpha-blockers relax the muscles in the prostate and bladder neck. This allows urine to flow out of the bladder more easily.


2. What you need to know before you take Urozosin


Do not take Urozosin


Warnings and precautions

Talk to your doctor or pharmacist before taking Urozosin


Swallow the tablets whole. Do not crush, powder or chew the tablets as too much of the active substance alfuzosin may reach your body too quickly. This may raise the risk of unwanted effects.


Children and adolescents

Urozosin is not indicated for use in children and adolescent.


Other medicines and Urozosin

Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.


Urozosin must not be taken if you take other medicines that belong to the group of alpha-blockers.


Urozosin and some medicines may interfere with each other. These include:


Urozosin with food and drink

Urozosin could be taken with or without food.


Pregancy and breast-feeding

This information is not relevant as Urozosin is only for men.


Driving and using machines

At the beginning of treatment with Urozosin you may feel light-headed, dizzy or weak. Do not drive or operate machinery or perform any hazardous tasks until you know how your body responds to the treatment.


Urozosin contains lactose

If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicinal product.


3. How to take Urozosin


Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.


The recommended dose is 1 prolonged-release tablet (5 mg alfuzosin) twice daily. Take the first tablet at bedtime. Swallow the tablets whole with a sufficient amount of fluid. Do not crush, chew or divide the tablets.


The usual dose for elderly patients (over 65 years) is 1 prolonged-release tablet (5 mg alfuzosin) once daily. Take the first tablet at bedtime. Your doctor may increase the dose to two times a day if needed.


The usual dose for patients with mild to moderate kidney problems is 1 prolonged-release tablet (5 mg alfuzosin once daily). Take the first tablet at bedtime.


If you take more Urozosin than you should

If you take large amounts of Urozosin your blood pressure may suddenly drop and you may feel dizzy or even faint. If you begin to feel dizzy, sit or lie down until you feel better. If the symptoms do not disappear, call your doctor as the drop in blood pressure may have to be treated in hospital.


If you forget to take Urozosin

Do not take a double dose to make up for a forgotten tablet as this may cause a sudden drop in blood pressure, especially if you take blood-pressure lowering medicines. Take the next tablet as directed.


If you stop taking Urozosin

You should not interrupt or stop taking Urozosin without speaking to your doctor first. If you want to stop the treatment or have any further questions on the use of this product, ask your doctor or pharmacist.


4. Possible side effects


Like all medicines, this medicine can cause side effects, although not everybody gets them.


If you get chest pain, stop taking Urozosin and contact a doctor or go to a hospital immediately. Sign of chest pain (angina) normally happens if you have had angina before. This side effect is very rare and may affect up to 1 in 10,000 people.


If you get symptoms such as red lumpy skin rash, swelling (of the face, tongue or throat), difficulty breathing or swallowingstop taking Urozosin and contact your doctor immediately. These are symptoms of angioedema, which is a very rare side effect that may affect up to 1 in 10,000 people.


Other side effects that can occur with Urozosin are:


Common(may affect up to 1 in 10 people):

Fainting/dizziness, headache, a spinning sensation in the head (vertigo), marked drop in blood pressure when standing up (especially when starting treatment with too high a dose and when treatment is resumed), stomach pain, feeling sick (nausea), diarrhoea, dry mouth, feeling of weakness, malaise.


Uncommon(may affect up to 1 in 100 people):

Feeling drowsy, loss of consciousness resulting from insufficient blood flow to the brain, eye problems, faster heartbeat, sensation of pounding or racing heartbeat, runny nose, skin rash, itching, water retention (may cause swollen arms, ankles or legs), reddening of the face (flushing), chest pain, uncomfortable feeling in the stomach and indigestion (dyspepsia), being sick (vomiting), lack of control over passing urine.


Not known( frequency cannot be estimated from the available data):

If you must undergo eye surgery because of a cataract and are taking Urozosin or have taken it in the past, difficulties during surgery may occur (see “Warnings and precautions”).


Very rapid uncoordinated contractions of the heart, abnormal liver function (signs may include yellowing of your skin or the whites of your eyes), persistent and painful penile erection (priapism), decrease in white blood cells. Low numbers of blood platelets. Signs may include bleeding from your gums and nose, bruising, prolonged bleeding from cuts, rash (pinpoint red spots called petechia). Decreased blood flow to parts of the brain in patients known to have vascular disturbances in the brain.


Reporting of side effects

If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V.By reporting side effects you can help provide more information on the safety of this medicine.


5. How to store Urozosin


Keep this medicine out of the sight and reach of children.


Do not use this medicine after the expiry date which is stated on the blister and carton. The expiry date refers to the last day of that month.


Do not store above 25°C.


Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.


6. Contents of the pack and other information


What Urozosin contains

The active substance is alfuzosin hydrochloride.


One prolonged-release tablet contains 5 mg alfuzosin hydrochloride.


The other ingredients are: lactose monohydrate, hypromellose (E 464), povidone K25, magnesium stearate (E 470 b).


What Urozosin looks like and contents of the pack

Urozosin are white, round, bevelled-edged, uncoated tablets.


Urozosin is available in blister packs with 20, 28, 30, 50, 56, 60, 60x1, 100 and 180 prolonged-release tablets.


Not all pack sizes may be marketed.


Marketing Authorisation Holder and Manufacturer

[To be completed nationally]


This medicinal product is authorised in the Member States of the EEA under the following names:

Austria: Alfuzosin Sandoz 5 mg – Retardtabletten

Greece: Zoprost

Netherlands: Alfuzosin HCl Sandoz retard 5

Spain: Alfuzosina Sandoz 5 mg comprimidos de

liberacion prolongada EFG

Sweden: Urozosin


This leaflet was last revised in 9 May 2016